Sanofi's CEO moves to Boston

Share this article:

Sanofi CEO Chris Viehbacher, who has dual German and Canadian citizenship, is moving to Boston. Bloomberg reports that the pharmaceutical chief will not only be closer to subsidiary Genzyme, which is across the Charles in Cambridge, MA, but will also be closer to Chief Strategy Officer David-Alexandre Gros, Genzyme's leader David Meeker and 12 members of the executive committee who also live in the US.

The move has the potential to offer Viehbacher a tax break, though Sanofi did not answer Bloomberg's questions about what this means in terms of what the CEO will pay in French taxes. The company said Viehbacher's move was for personal reasons.

A new city can be hard (haahd in Massachusetts speak), but Wikipedia's got this helpful dictionary for those looking to brush up on their Boston-isms, or just for a handy guide when subtitles would be much appreciated.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Avastin pockets another Priority Review label

It's the second for this cancer drug in two weeks.

Court invalidates some healthcare subsidies

The lawsuit has been wending its way through the courts for a while, and, although it is being deliberated in several other venues, the decision is part of a legal dispute that puts patients in the 36 states offering federal exchanges in limbo.

FDA generic division overhaul kicks in

The Food and Drug Administration has been intent on elevating and reorganizing its office of Generic Drugs since 2012.